<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">actabiomedica</journal-id><journal-title-group><journal-title xml:lang="ru">Acta Biomedica Scientifica</journal-title><trans-title-group xml:lang="en"><trans-title>Acta Biomedica Scientifica</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2541-9420</issn><issn pub-type="epub">2587-9596</issn><publisher><publisher-name>Scientific Centre for Family Health and Human Reproduction Problems</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29413/ABS.2024-9.2.2</article-id><article-id custom-type="elpub" pub-id-type="custom">actabiomedica-4723</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ДИСКУССИОННЫЕ СТАТЬИ, ЛЕКЦИИ, НОВЫЕ ТРЕНДЫ МЕДИЦИНСКОЙ НАУКИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>DISCUSSION PAPERS, LECTURES, NEW TRENDS IN MEDICAL SCIENCE</subject></subj-group></article-categories><title-group><article-title>Мелатонин и микробиота кишечника</article-title><trans-title-group xml:lang="en"><trans-title>Melatonin and gut microbiome</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4396-2096</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гаращенко</surname><given-names>Н. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Garashchenko</surname><given-names>N. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гаращенко Надежда Евгеньевна – аспирант.</p><p>664003, Иркутск, ул. Тимирязева, 16</p></bio><bio xml:lang="en"><p>Nadezhda E. Garashchenko – Postgraduate.</p><p>Timiryazeva str. 16, Irkutsk 664003</p></bio><email xlink:type="simple">nadzelin@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6512-1335</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Семёнова</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Semenova</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Семёнова Наталья Викторовна – доктор биологических наук, главный научный сотрудник лаборатории патофизиологии.</p><p>664003, Иркутск, ул. Тимирязева, 16</p></bio><bio xml:lang="en"><p>Natalya V. Semenova – Dr. Sc. (Biol.), Leading Research Officer at the Laboratory of Pathophysiology.</p><p>Timiryazeva str. 16, Irkutsk 664003</p></bio><email xlink:type="simple">natkor_84@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3354-2992</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Колесникова</surname><given-names>Л. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Kolesnikova</surname><given-names>L. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Колесникова Любовь Ильинична – доктор медицинских наук, профессор, академик РАН, научный руководитель.</p><p>664003, Иркутск, ул. Тимирязева, 16</p></bio><bio xml:lang="en"><p>Lyubov I. Kolesnikova – Dr. Sc. (Med.), Professor, Member of RAS, Academic Advisor.</p><p>Timiryazeva str. 16, Irkutsk 664003</p></bio><email xlink:type="simple">kolesnikova20121@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Научный центр проблем здоровья семьи и репродукции человека»</institution></aff><aff xml:lang="en"><institution>Scientific Centre for Family Health and Human Reproduction Problems</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>30</day><month>05</month><year>2024</year></pub-date><volume>9</volume><issue>2</issue><fpage>12</fpage><lpage>23</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Гаращенко Н.Е., Семёнова Н.В., Колесникова Л.И., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Гаращенко Н.Е., Семёнова Н.В., Колесникова Л.И.</copyright-holder><copyright-holder xml:lang="en">Garashchenko N.E., Semenova N.V., Kolesnikova L.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.actabiomedica.ru/jour/article/view/4723">https://www.actabiomedica.ru/jour/article/view/4723</self-uri><abstract><p>Изучение микробиома человека в последние годы привело к созданию теории «Ось кишечник – мозг», которая предполагает наличие взаимосвязи между бактериальным сообществом кишечника и его метаболитами и химическими соединениями, а также физиологическими и патологическими процессами головного мозга. Одним из потенциальных звеньев этой взаимосвязи считается мелатонин.</p><p>В обзоре представлена краткая информация о синтезе, метаболизме и эффектах мелатонина в организме. Рассмотрены общие паттерны влияния мелатонина на микробиоту кишечника в различных условиях, таких как пероральное и интраперитонеальное введение мелатонина, депривация сна, а также результаты изучения микробного сообщества с измерением уровня гормона.</p><p>Приведены результаты для семейств и отдельных родов микроорганизмов, полученные в исследованиях на животных моделях или при изучении заболеваний. В статье также отмечены некоторые дополнительные параметры, предположительно имеющие отношение к взаимодействию мелатонина с микробиотой кишечника. Отдельное внимание уделено бутирату как одному из наиболее изученных возможных участников этого взаимодействия. Изучение взаимосвязи между мелатонином и микробиомом представляет интерес для фундаментальной науки и практической медицины.</p><p>Поиск литературных источников был осуществлён с использованием электронных информационных ресурсов PubMed и eLibrary.</p></abstract><trans-abstract xml:lang="en"><p>In recent years, studies of the human microbiome have led to the development of the gut-brain axis theory, which proposes a relationship between the gut bacterial community and its metabolites and chemical compounds, as well as physiological and pathological processes in the brain. Melatonin is considered one of the potential links in this relationship.</p><p>The review provides brief information about the synthesis, metabolism and effects of melatonin in the body. General patterns of the effect of melatonin on the intestinal microbiota under various conditions, such as oral and intraperitoneal melatonin administration, sleep deprivation, as well as the results of studying the microbial community with measurement of hormone levels are considered.</p><p>Results are presented for families and individual genera of microorganisms and are obtained from studies in animal models or in the research of diseases. The article also notes some additional parameters which are supposed to be relevant to the interaction of melatonin with gut microbiome. Special attention is paid to butyrate as one of the most studied possible parts in this interaction. Studying the relationship between melatonin and microbiome is of interest for basic science and practical medicine.</p><p>Literature search was carried out using electronic information resources PubMed and eLibrary.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>мелатонин</kwd><kwd>микробиом</kwd><kwd>бутират</kwd><kwd>депривация сна</kwd><kwd>ось «кишечник – мозг»</kwd></kwd-group><kwd-group xml:lang="en"><kwd>melatonin</kwd><kwd>microbiome</kwd><kwd>butyrate</kwd><kwd>sleep deprivation</kwd><kwd>gut-brain axis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ghosh TS, Shanahan F, O’Toole PW. The gut microbiome as a modulator of healthy ageing. Nat Rev Gastroenterol Hepatol. 2022; 19(9): 565-584. doi: 10.1038/s41575-022-00605-x</mixed-citation><mixed-citation xml:lang="en">Ghosh TS, Shanahan F, O’Toole PW. The gut microbiome as a modulator of healthy ageing. Nat Rev Gastroenterol Hepatol. 2022; 19(9): 565-584. doi: 10.1038/s41575-022-00605-x</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Klimenko ES, Belkova NL, Romanitsa AI, Pogodina AV, Rychkova LV, Darenskaya MA. Differences in gut microbiota composition and predicted metabolic functions: A pilot study of adolescents with normal weight and obesity. Bull Exp Biol Med. 2022; 173(5): 628-632. doi: 10.1007/s10517-022-05601-4</mixed-citation><mixed-citation xml:lang="en">Klimenko ES, Belkova NL, Romanitsa AI, Pogodina AV, Rychkova LV, Darenskaya MA. Differences in gut microbiota composition and predicted metabolic functions: A pilot study of adolescents with normal weight and obesity. Bull Exp Biol Med. 2022; 173(5): 628-632. doi: 10.1007/s10517-022-05601-4</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Weersma RK, Zhernakova A, Fu J. Interaction between drugs and the gut microbiome. Gut. 2020; 69(8): 1510-1519. doi: 10.1136/gutjnl-2019-320204</mixed-citation><mixed-citation xml:lang="en">Weersma RK, Zhernakova A, Fu J. Interaction between drugs and the gut microbiome. Gut. 2020; 69(8): 1510-1519. doi: 10.1136/gutjnl-2019-320204</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Yang L, Hung LY, Zhu Y, Ding S, Margolis KG, Leong KW. Material engineering in gut microbiome and human health. Research. 2022; 2022: 9804014. doi: 10.34133/2022/9804014</mixed-citation><mixed-citation xml:lang="en">Yang L, Hung LY, Zhu Y, Ding S, Margolis KG, Leong KW. Material engineering in gut microbiome and human health. Research. 2022; 2022: 9804014. doi: 10.34133/2022/9804014</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Савинова Ю.С., Белькова Н.Л., Семёнова Н.В., Рычкова Л.В. История, современные направления и перспективы развития прои пребиотических препаратов в России и за рубежом. Acta biomedica scientifica. 2022; 7(5-1): 211-227. doi: 10.29413/ABS.2022-7.5-1.23</mixed-citation><mixed-citation xml:lang="en">Savinova YuS, Belkova NL, Semenova NV, Rychkova LV. History, current trends and prospects for the development of proand prebiotic drugs in Russia and abroad. Acta biomedica scientifica. 2022; 7(5-1): 211-227. (In Russ.). doi: 10.29413/ABS.2022-7.5-1.23</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Suturina L, Belkova N, Igumnov I, Lazareva L, Danusevich I, Nadeliaeva I, et al. Polycystic ovary syndrome and gut microbiota: Phenotype matters. Life. 2022; 13(1): 7. doi: 10.3390/life13010007</mixed-citation><mixed-citation xml:lang="en">Suturina L, Belkova N, Igumnov I, Lazareva L, Danusevich I, Nadeliaeva I, et al. Polycystic ovary syndrome and gut microbiota: Phenotype matters. Life. 2022; 13(1): 7. doi: 10.3390/life13010007</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Sasso JM, Ammar RM, Tenchov R, Lemmel S, Kelber O, Grieswelle M, et al. Gut microbiome–brain alliance: A landscape view into mental and gastrointestinal health and disorders. ACS Chem Neurosci. 2023; 14(10): 1717-1763. doi: 10.1021/acschemneuro.3c00127</mixed-citation><mixed-citation xml:lang="en">Sasso JM, Ammar RM, Tenchov R, Lemmel S, Kelber O, Grieswelle M, et al. Gut microbiome–brain alliance: A landscape view into mental and gastrointestinal health and disorders. ACS Chem Neurosci. 2023; 14(10): 1717-1763. doi: 10.1021/acschemneuro.3c00127</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Wang B, Duan R, Duan L. Prevalence of sleep disorder in irritable bowel syndrome: A systematic review with meta-analysis. Saudi JGastroenterol. 2018; 24(3): 141. doi: 10.4103/sjg.SJG_603_17</mixed-citation><mixed-citation xml:lang="en">Wang B, Duan R, Duan L. Prevalence of sleep disorder in irritable bowel syndrome: A systematic review with meta-analysis. Saudi JGastroenterol. 2018; 24(3): 141. doi: 10.4103/sjg.SJG_603_17</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Wong RK, Yang C, Song G-H, Wong J, Ho K-Y. Melatonin regulation as a possible mechanism for probiotic (VSL#3) in irritable bowel syndrome: A randomized double-blinded placebo study. Dig Dis Sci. 2015; 60(1): 186-194. doi: 10.1007/s10620-014-3299-8</mixed-citation><mixed-citation xml:lang="en">Wong RK, Yang C, Song G-H, Wong J, Ho K-Y. Melatonin regulation as a possible mechanism for probiotic (VSL#3) in irritable bowel syndrome: A randomized double-blinded placebo study. Dig Dis Sci. 2015; 60(1): 186-194. doi: 10.1007/s10620-014-3299-8</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Семёнова Н.В., Мадаева И.М., Колесникова Л.И. Инсомния и циркадные ритмы мелатонина у женщин в менопаузе. Acta biomedica scientifica. 2018; 3(5): 16-21. doi: 10.29413/ABS.2018-3.5.2</mixed-citation><mixed-citation xml:lang="en">Semenova NV, Madaeva IM, Kolesnikova LI. Insomnia and circadian rhythms of melatonin in menopausal women. Acta biomedica scientifica. 2018; 3(5): 16-21. (In Russ.). doi: 10.29413/ABS.2018-3.5.2</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Цветкова Е.С., Романцова Т.И., Полуэктов М.Г., Рунова Г.Е., Глинкина И.В., Фадеев В.В. Значение мелатонина в регуляции метаболизма, пищевого поведения, сна и перспективы его применения при экзогенно-конституциональном ожирении. Ожирение и метаболизм. 2021; 18(2): 112-124. doi: 10.14341/omet12279</mixed-citation><mixed-citation xml:lang="en">Tsvetkova ES, Romantsova TI, Poluektov MG, Runova GE, Glinkina IV, Fadeev VV. The importance of melatonin in the regulation of metabolism, eating behavior, sleep, and the prospects for the use of melatonin drugs for obesity treatment. Obesity and Metabolism. 2021; 18(2): 112-124. (In Russ.). doi: 10.14341/omet12279</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Семенова Н.В., Мадаева И.М., Колесникова Л.И. Роль мелатонина как компонента антиоксидантной защиты при инсомнии в перименопаузе. Журнал неврологии и психиатрии им. C.C. Корсакова. 2019; 119(7): 7-13. doi: 10.17116/jnevro20191190717</mixed-citation><mixed-citation xml:lang="en">Semenova NV, Madaeva IM, Kolesnikova LI. The role of melatonin as a component of the antioxidant defense system in perimenopausal women with insomnia. S.S. Korsakov Journal of Neurology and Psychiatry. 2019; 119(7): 7. (In Russ.). doi: 10.17116/jnevro20191190717</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kolesnikova LI, Madaeva IM, Semenova NV, Suturina LV, Berdina ON, Sholohov LF, et al. Pathogenic role of melatonin in sleep disorders in menopausal women. Bull Exp Biol Med. 2013; 156(1): 104-106. doi: 10.1007/s10517-013-2289-8</mixed-citation><mixed-citation xml:lang="en">Kolesnikova LI, Madaeva IM, Semenova NV, Suturina LV, Berdina ON, Sholohov LF, et al. Pathogenic role of melatonin in sleep disorders in menopausal women. Bull Exp Biol Med. 2013; 156(1): 104-106. doi: 10.1007/s10517-013-2289-8</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Berdina ON, Madaeva IM, Bolshakova SE, Tsykunova MV, Sholokhov LF, Rashidova MA, et al. Circadian melatonin secretion in obese adolescents with or without obstructive sleep apnea. Russ Open Med J. 2020; 9(4): e0402. doi: 10.15275/rusomj.2020.0402</mixed-citation><mixed-citation xml:lang="en">Berdina ON, Madaeva IM, Bolshakova SE, Tsykunova MV, Sholokhov LF, Rashidova MA, et al. Circadian melatonin secretion in obese adolescents with or without obstructive sleep apnea. Russ Open Med J. 2020; 9(4): e0402. doi: 10.15275/rusomj.2020.0402</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Kvetnoy I, Ivanov D, Mironova E, Evsyukova I, Nasyrov R, Kvetnaia T, et al. Melatonin as the cornerstone of neuroimmunoendocrinology. Int J Mol Sci. 2022; 23(3): 1835. doi: 10.3390/ijms23031835</mixed-citation><mixed-citation xml:lang="en">Kvetnoy I, Ivanov D, Mironova E, Evsyukova I, Nasyrov R, Kvetnaia T, et al. Melatonin as the cornerstone of neuroimmunoendocrinology. Int J Mol Sci. 2022; 23(3): 1835. doi: 10.3390/ijms23031835</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Acuña-Castroviejo D, Escames G, Venegas C, Díaz-Casado ME, Lima-Cabello E, López LC, et al. Extrapineal melatonin: Sources, regulation, and potential functions. Cell Mol Life Sci. 2014; 71(16): 2997-3025. doi: 10.1007/s00018-014-1579-2</mixed-citation><mixed-citation xml:lang="en">Acuña-Castroviejo D, Escames G, Venegas C, Díaz-Casado ME, Lima-Cabello E, López LC, et al. Extrapineal melatonin: Sources, regulation, and potential functions. Cell Mol Life Sci. 2014; 71(16): 2997-3025. doi: 10.1007/s00018-014-1579-2</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Cipolla-Neto J, Amaral FGD. Melatonin as a hormone: New physiological and clinical insights. Endocr Rev. 2018; 39(6): 990-1028. doi: 10.1210/er.2018-00084</mixed-citation><mixed-citation xml:lang="en">Cipolla-Neto J, Amaral FGD. Melatonin as a hormone: New physiological and clinical insights. Endocr Rev. 2018; 39(6): 990-1028. doi: 10.1210/er.2018-00084</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Söderquist F, Hellström PM, Cunningham JL. Human gastroenteropancreatic expression of melatonin and its receptors MT1 and MT2. PLos One. 2015; 10(3): e0120195. doi: 10.1371/journal.pone.0120195</mixed-citation><mixed-citation xml:lang="en">Söderquist F, Hellström PM, Cunningham JL. Human gastroenteropancreatic expression of melatonin and its receptors MT1 and MT2. PLos One. 2015; 10(3): e0120195. doi: 10.1371/journal.pone.0120195</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Wang B, Zhu S, Liu Z, Wei H, Zhang L, He M, et al. Increased expression of colonic mucosal melatonin in patients with irritable bowel syndrome correlated with gut dysbiosis. Genomics Proteomics Bioinformatics. 2020; 18(6): 708-720. doi: 10.1016/j.gpb.2020.06.013</mixed-citation><mixed-citation xml:lang="en">Wang B, Zhu S, Liu Z, Wei H, Zhang L, He M, et al. Increased expression of colonic mucosal melatonin in patients with irritable bowel syndrome correlated with gut dysbiosis. Genomics Proteomics Bioinformatics. 2020; 18(6): 708-720. doi: 10.1016/j.gpb.2020.06.013</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Yu H, Dickson EJ, Jung S-R, Koh D-S, Hille B. High membrane permeability for melatonin. J Gen Physiol. 2016; 147(1): 63-76. doi: 10.1085/jgp.201511526</mixed-citation><mixed-citation xml:lang="en">Yu H, Dickson EJ, Jung S-R, Koh D-S, Hille B. High membrane permeability for melatonin. J Gen Physiol. 2016; 147(1): 63-76. doi: 10.1085/jgp.201511526</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Masters A, Pandi-Perumal SR, Seixas A, Girardin J-L, McFarlane SI. Melatonin, the hormone of darkness: From sleep promotion to Ebola treatment. Brain Disord Ther. 2014; 04(01): 1000151. doi: 10.4172/2168-975X.1000151</mixed-citation><mixed-citation xml:lang="en">Masters A, Pandi-Perumal SR, Seixas A, Girardin J-L, McFarlane SI. Melatonin, the hormone of darkness: From sleep promotion to Ebola treatment. Brain Disord Ther. 2014; 04(01): 1000151. doi: 10.4172/2168-975X.1000151</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Chojnacki C. Evaluation of enterochromaffin cells and melatonin secretion exponents in ulcerative colitis. World J Gastroenterol. 2013; 19(23): 3602. doi: 10.3748/wjg.v19.i23.3602</mixed-citation><mixed-citation xml:lang="en">Chojnacki C. Evaluation of enterochromaffin cells and melatonin secretion exponents in ulcerative colitis. World J Gastroenterol. 2013; 19(23): 3602. doi: 10.3748/wjg.v19.i23.3602</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Paulose JK, Cassone CV, Cassone VM. Aging, melatonin biosynthesis, and circadian clockworks in the gastrointestinal system of the laboratory mouse. Physiol Genomics. 2019; 51(1): 1-9. doi: 10.1152/physiolgenomics.00095.2018</mixed-citation><mixed-citation xml:lang="en">Paulose JK, Cassone CV, Cassone VM. Aging, melatonin biosynthesis, and circadian clockworks in the gastrointestinal system of the laboratory mouse. Physiol Genomics. 2019; 51(1): 1-9. doi: 10.1152/physiolgenomics.00095.2018</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Su W-L, Wu C-C, Wu S-FV, Lee M-C, Liao M-T, Lu K-C, et al. A review of the potential effects of melatonin in compromised mitochondrial redox activities in elderly patients with COVID-19. Front Nutr. 2022; 9: 865321. doi: 10.3389/fnut.2022.865321</mixed-citation><mixed-citation xml:lang="en">Su W-L, Wu C-C, Wu S-FV, Lee M-C, Liao M-T, Lu K-C, et al. A review of the potential effects of melatonin in compromised mitochondrial redox activities in elderly patients with COVID-19. Front Nutr. 2022; 9: 865321. doi: 10.3389/fnut.2022.865321</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Семёнова Н.В. Окислительный стресс и менопауза (обзор литературы). Acta biomedica scientifica. 2014; (2): 120-125.</mixed-citation><mixed-citation xml:lang="en">Semyonova NV. Oxidative stress and menopause (review of literature). Acta biomedica scientifica. 2014; (2):120-125. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Панов А.В., Дикалов С.И., Даренская М.А., Рычкова Л.В., Колесникова Л.И., Колесников С.И. Митохондрии: старение, метаболический синдром и сердечно-сосудистая патология. Становление новой парадигмы. Acta biomedica scientifica. 2020; 5(4): 33-44. doi: 10.29413/ABS.2020-5.4.5</mixed-citation><mixed-citation xml:lang="en">Panov AV, Dikalov SI, Darenskaya MA, Rychkova LV, Kolesnikova LI, Kolesnikov SI. Mitochondria: aging, metabolic syndrome and cardiovascular diseases. Formation of a new paradigm. Acta biomedica scientifica. 2020; 5(4): 33-44. (In Russ.). doi: 10.29413/ABS.2020-5.4.5</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Darenskaya M, Rychkova L, Semenova N, Belkova N, Kolesnikova L. The role of oxidative stress and changes in the composition of the gut microbiota in the genesis of adolescent obesity. Int J Biomed. 2022; 12(3): 344-348. doi: 10.21103/Article12(3)_RA3</mixed-citation><mixed-citation xml:lang="en">Darenskaya M, Rychkova L, Semenova N, Belkova N, Kolesnikova L. The role of oxidative stress and changes in the composition of the gut microbiota in the genesis of adolescent obesity. Int J Biomed. 2022; 12(3): 344-348. doi: 10.21103/Article12(3)_RA3</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Diaz De Barboza G, Guizzardi S, Moine L, Tolosa De Talamoni N. Oxidative stress, antioxidants and intestinal calcium absorption. World J Gastroenterol. 2017; 23(16): 2841. doi: 10.3748/wjg.v23.i16.2841</mixed-citation><mixed-citation xml:lang="en">Diaz De Barboza G, Guizzardi S, Moine L, Tolosa De Talamoni N. Oxidative stress, antioxidants and intestinal calcium absorption. World J Gastroenterol. 2017; 23(16): 2841. doi: 10.3748/wjg.v23.i16.2841</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Gao T, Wang Z, Cao J, Dong Y, Chen Y. Melatonin attenuates microbiota dysbiosis of jejunum in short-term sleep deprived mice. J Microbiol. 2020; 58(7): 588-597. doi: 10.1007/s12275-020-0094-4</mixed-citation><mixed-citation xml:lang="en">Gao T, Wang Z, Cao J, Dong Y, Chen Y. Melatonin attenuates microbiota dysbiosis of jejunum in short-term sleep deprived mice. J Microbiol. 2020; 58(7): 588-597. doi: 10.1007/s12275-020-0094-4</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Yin J, Li Y, Han H, Chen S, Gao J, Liu G, et al. Melatonin reprogramming of gut microbiota improves lipid dysmetabo lism in high‐fat diet‐fed mice. J Pineal Res. 2018; 65(4): e12524. doi: 10.1111/jpi.12524</mixed-citation><mixed-citation xml:lang="en">Yin J, Li Y, Han H, Chen S, Gao J, Liu G, et al. Melatonin reprogramming of gut microbiota improves lipid dysmetabo lism in high‐fat diet‐fed mice. J Pineal Res. 2018; 65(4): e12524. doi: 10.1111/jpi.12524</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang H, Liu X, Zheng Y, Zha X, Elsabagh M, Zhang Y, et al. Effects of the maternal gut microbiome and gut-placental axis on melatonin efficacy in alleviating cadmium-induced fetal growth restriction. Ecotoxicol Environ Saf. 2022; 237: 113550. doi: 10.1016/j.ecoenv.2022.113550</mixed-citation><mixed-citation xml:lang="en">Zhang H, Liu X, Zheng Y, Zha X, Elsabagh M, Zhang Y, et al. Effects of the maternal gut microbiome and gut-placental axis on melatonin efficacy in alleviating cadmium-induced fetal growth restriction. Ecotoxicol Environ Saf. 2022; 237: 113550. doi: 10.1016/j.ecoenv.2022.113550</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang SL, Bai L, Goel N, Bailey A, Jang CJ, Bushman FD, et al. Human and rat gut microbiome composition is maintained following sleep restriction. Proc Natl Acad Sci. 2017; 114(8). doi: 10.1073/pnas.1620673114</mixed-citation><mixed-citation xml:lang="en">Zhang SL, Bai L, Goel N, Bailey A, Jang CJ, Bushman FD, et al. Human and rat gut microbiome composition is maintained following sleep restriction. Proc Natl Acad Sci. 2017; 114(8). doi: 10.1073/pnas.1620673114</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Xu P, Wang J, Hong F, Wang S, Jin X, Xue T, et al. Melatonin prevents obesity through modulation of gut microbiota in mice. J Pineal Res. 2017; 62(4): e12399. doi: 10.1111/jpi.12399</mixed-citation><mixed-citation xml:lang="en">Xu P, Wang J, Hong F, Wang S, Jin X, Xue T, et al. Melatonin prevents obesity through modulation of gut microbiota in mice. J Pineal Res. 2017; 62(4): e12399. doi: 10.1111/jpi.12399</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Benedict C, Vogel H, Jonas W, Woting A, Blaut M, Schürmann A, et al. Gut microbiota and glucometabolic alterations in response to recurrent partial sleep deprivation in normal-weight young individuals. Mol Metab. 2016; 5(12): 1175-1186. doi: 10.1016/j.molmet.2016.10.003</mixed-citation><mixed-citation xml:lang="en">Benedict C, Vogel H, Jonas W, Woting A, Blaut M, Schürmann A, et al. Gut microbiota and glucometabolic alterations in response to recurrent partial sleep deprivation in normal-weight young individuals. Mol Metab. 2016; 5(12): 1175-1186. doi: 10.1016/j.molmet.2016.10.003</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Park YS, Kim SH, Park JW, Kho Y, Seok PR, Shin J-H, et al. Melatonin in the colon modulates intestinal microbiota in response to stress and sleep deprivation. Intest Res. 2020; 18(3): 325-336. doi: 10.5217/ir.2019.00093</mixed-citation><mixed-citation xml:lang="en">Park YS, Kim SH, Park JW, Kho Y, Seok PR, Shin J-H, et al. Melatonin in the colon modulates intestinal microbiota in response to stress and sleep deprivation. Intest Res. 2020; 18(3): 325-336. doi: 10.5217/ir.2019.00093</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Paulose JK, Wright JM, Patel AG, Cassone VM. Human gut bacteria are sensitive to melatonin and express endogenous circadian rhythmicity. PLos One. 2016; 11(1): e0146643. doi: 10.1371/journal.pone.0146643</mixed-citation><mixed-citation xml:lang="en">Paulose JK, Wright JM, Patel AG, Cassone VM. Human gut bacteria are sensitive to melatonin and express endogenous circadian rhythmicity. PLos One. 2016; 11(1): e0146643. doi: 10.1371/journal.pone.0146643</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Song L, He M, Sun Q, Wang Y, Zhang J, Fang Y, et al. Roseburia hominis increases intestinal melatonin level by activating p-CREB-AANAT Pathway. Nutrients. 2021; 14(1): 117. doi: 10.3390/nu14010117</mixed-citation><mixed-citation xml:lang="en">Song L, He M, Sun Q, Wang Y, Zhang J, Fang Y, et al. Roseburia hominis increases intestinal melatonin level by activating p-CREB-AANAT Pathway. Nutrients. 2021; 14(1): 117. doi: 10.3390/nu14010117</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Gao T, Wang Z, Dong Y, Cao J, Chen Y. Melatonin-mediated colonic microbiota metabolite butyrate prevents acute sleep deprivation-induced colitis in mice. Int J Mol Sci. 2021; 22(21): 11894. doi: 10.3390/ijms222111894</mixed-citation><mixed-citation xml:lang="en">Gao T, Wang Z, Dong Y, Cao J, Chen Y. Melatonin-mediated colonic microbiota metabolite butyrate prevents acute sleep deprivation-induced colitis in mice. Int J Mol Sci. 2021; 22(21): 11894. doi: 10.3390/ijms222111894</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao Z, Yuan X, Cui Y, Liu J, Shen J, Jin B, et al. Melatonin mitigates oxazolone-induced colitis in microbiota-dependent manner. Front Immunol. 2022; 12: 783806. doi: 10.3389/fimmu.2021.783806</mixed-citation><mixed-citation xml:lang="en">Zhao Z, Yuan X, Cui Y, Liu J, Shen J, Jin B, et al. Melatonin mitigates oxazolone-induced colitis in microbiota-dependent manner. Front Immunol. 2022; 12: 783806. doi: 10.3389/fimmu.2021.783806</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Huang X, Qiu Y, Gao Y, Zhou R, Hu Q, He Z, et al. Gut microbiota mediate melatonin signalling in association with type 2 diabetes. Diabetologia. 2022; 65(10): 1627-1641. doi: 10.1007/s00125-022-05747-w</mixed-citation><mixed-citation xml:lang="en">Huang X, Qiu Y, Gao Y, Zhou R, Hu Q, He Z, et al. Gut microbiota mediate melatonin signalling in association with type 2 diabetes. Diabetologia. 2022; 65(10): 1627-1641. doi: 10.1007/s00125-022-05747-w</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Hua X, Zhu J, Yang T, Guo M, Li Q, Chen J, et al. The gut microbiota and associated metabolites are altered in sleep disorder of children with autism spectrum disorders. Front Psychiatry. 2020; 11: 855. doi: 10.3389/fpsyt.2020.00855</mixed-citation><mixed-citation xml:lang="en">Hua X, Zhu J, Yang T, Guo M, Li Q, Chen J, et al. The gut microbiota and associated metabolites are altered in sleep disorder of children with autism spectrum disorders. Front Psychiatry. 2020; 11: 855. doi: 10.3389/fpsyt.2020.00855</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Iesanu MI, Zahiu CDM, Dogaru I-A, Chitimus DM, Pircalabioru GG, Voiculescu SE, et al. Melatonin–microbiome two-sided interaction in dysbiosis-associated conditions. Antioxidants. 2022; 11(11): 2244. doi: 10.3390/antiox11112244</mixed-citation><mixed-citation xml:lang="en">Iesanu MI, Zahiu CDM, Dogaru I-A, Chitimus DM, Pircalabioru GG, Voiculescu SE, et al. Melatonin–microbiome two-sided interaction in dysbiosis-associated conditions. Antioxidants. 2022; 11(11): 2244. doi: 10.3390/antiox11112244</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Wang T, Wang Z, Cao J, Dong Y, Chen Y. Melatonin prevents the dysbiosis of intestinal microbiota in sleep-restricted mice by improving oxidative stress and inhibiting inflammation. Saudi J Gastroenterol. 2022; 28(3): 209. doi: 10.4103/sjg.sjg_110_21</mixed-citation><mixed-citation xml:lang="en">Wang T, Wang Z, Cao J, Dong Y, Chen Y. Melatonin prevents the dysbiosis of intestinal microbiota in sleep-restricted mice by improving oxidative stress and inhibiting inflammation. Saudi J Gastroenterol. 2022; 28(3): 209. doi: 10.4103/sjg.sjg_110_21</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Wrzosek L, Miquel S, Noordine M-L, Bouet S, ChevalierCurt MJ, Robert V, et al. Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol. 2013; 11(1): 61. doi: 10.1186/1741-7007-11-61</mixed-citation><mixed-citation xml:lang="en">Wrzosek L, Miquel S, Noordine M-L, Bouet S, ChevalierCurt MJ, Robert V, et al. Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol. 2013; 11(1): 61. doi: 10.1186/1741-7007-11-61</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Gao T, Wang Z, Cao J, Dong Y, Chen Y. Melatonin alleviates oxidative stress in sleep deprived mice: Involvement of small intestinal mucosa injury. Int Immunopharmacol. 2020; 78: 106041. doi: 10.1016/j.intimp.2019.106041</mixed-citation><mixed-citation xml:lang="en">Gao T, Wang Z, Cao J, Dong Y, Chen Y. Melatonin alleviates oxidative stress in sleep deprived mice: Involvement of small intestinal mucosa injury. Int Immunopharmacol. 2020; 78: 106041. doi: 10.1016/j.intimp.2019.106041</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Wu Y, He F, Zhang C, Zhang Q, Su X, Zhu X, et al. Melatonin alleviates titanium nanoparticles induced osteolysis via activation of butyrate/GPR109A signaling pathway. J Nanobiotechnology. 2021; 19(1): 170. doi: 10.1186/s12951-021-00915-3</mixed-citation><mixed-citation xml:lang="en">Wu Y, He F, Zhang C, Zhang Q, Su X, Zhu X, et al. Melatonin alleviates titanium nanoparticles induced osteolysis via activation of butyrate/GPR109A signaling pathway. J Nanobiotechnology. 2021; 19(1): 170. doi: 10.1186/s12951-021-00915-3</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Bishayi B, Adhikary R, Nandi A, Sultana S. Beneficial effects of exogenous melatonin in acute Staphylococcus Aureus and Escherichia Coli infection-induced inflammation and associated behavioral response in mice after exposure to short photoperiod. Inflammation. 2016; 39(6): 2072-2093. doi: 10.1007/s10753-0160445-9</mixed-citation><mixed-citation xml:lang="en">Bishayi B, Adhikary R, Nandi A, Sultana S. Beneficial effects of exogenous melatonin in acute Staphylococcus Aureus and Escherichia Coli infection-induced inflammation and associated behavioral response in mice after exposure to short photoperiod. Inflammation. 2016; 39(6): 2072-2093. doi: 10.1007/s10753-0160445-9</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">He F, Wu X, Zhang Q, Li Y, Ye Y, Li P, et al. Bacteriostatic potential of melatonin: therapeutic standing and mechanistic insights. Front Immunol. 2021; 12: 683879. doi: 10.3389/fimmu.2021.683879</mixed-citation><mixed-citation xml:lang="en">He F, Wu X, Zhang Q, Li Y, Ye Y, Li P, et al. Bacteriostatic potential of melatonin: therapeutic standing and mechanistic insights. Front Immunol. 2021; 12: 683879. doi: 10.3389/fimmu.2021.683879</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Luo H, Schneider K, Christensen U, Lei Y, Herrgard M, Palsson BØ. Microbial synthesis of human-hormone melatonin at gram scales. ACS Synth Biol. 2020; 9(6): 1240-1245. doi: 10.1021/acssynbio.0c00065</mixed-citation><mixed-citation xml:lang="en">Luo H, Schneider K, Christensen U, Lei Y, Herrgard M, Palsson BØ. Microbial synthesis of human-hormone melatonin at gram scales. ACS Synth Biol. 2020; 9(6): 1240-1245. doi: 10.1021/acssynbio.0c00065</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Anderson G, Rodriguez M, Reiter RJ. Multiple sclerosis: Melatonin, orexin, and ceramide interact with platelet activation coagulation factors and gut-microbiome-derived butyrate in the circadian dysregulation of mitochondria in glia and immune cells. Int J Mol Sci. 2019; 20(21): 5500. doi: 10.3390/ijms20215500</mixed-citation><mixed-citation xml:lang="en">Anderson G, Rodriguez M, Reiter RJ. Multiple sclerosis: Melatonin, orexin, and ceramide interact with platelet activation coagulation factors and gut-microbiome-derived butyrate in the circadian dysregulation of mitochondria in glia and immune cells. Int J Mol Sci. 2019; 20(21): 5500. doi: 10.3390/ijms20215500</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Jin CJ, Engstler AJ, Sellmann C, Ziegenhardt D, Landmann M, Kanuri G, et al. Sodium butyrate protects mice from the development of the early signs of non-alcoholic fatty liver disease: Role of melatonin and lipid peroxidation. Br J Nutr. 2016; 116(10): 1682-1693. doi: 10.1017/S0007114516004025</mixed-citation><mixed-citation xml:lang="en">Jin CJ, Engstler AJ, Sellmann C, Ziegenhardt D, Landmann M, Kanuri G, et al. Sodium butyrate protects mice from the development of the early signs of non-alcoholic fatty liver disease: Role of melatonin and lipid peroxidation. Br J Nutr. 2016; 116(10): 1682-1693. doi: 10.1017/S0007114516004025</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Baumann A, Jin C, Brandt A, Sellmann C, Nier A, Burkard M, et al. Oral supplementation of sodium butyrate attenuates the progression of non-alcoholic steatohepatitis. Nutrients. 2020; 12(4): 951. doi: 10.3390/nu12040951</mixed-citation><mixed-citation xml:lang="en">Baumann A, Jin C, Brandt A, Sellmann C, Nier A, Burkard M, et al. Oral supplementation of sodium butyrate attenuates the progression of non-alcoholic steatohepatitis. Nutrients. 2020; 12(4): 951. doi: 10.3390/nu12040951</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Averina OV, Kovtun AS, Polyakova SI, Savilova AM, Rebrikov DV, Danilenko VN. The bacterial neurometabolic signature of the gut microbiota of young children with autism spectrum disorders. J Med Microbiol. 2020; 69(4): 558-571. doi: 10.1099/jmm.0.001178</mixed-citation><mixed-citation xml:lang="en">Averina OV, Kovtun AS, Polyakova SI, Savilova AM, Rebrikov DV, Danilenko VN. The bacterial neurometabolic signature of the gut microbiota of young children with autism spectrum disorders. J Med Microbiol. 2020; 69(4): 558-571. doi: 10.1099/jmm.0.001178</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Kovtun AS, Averina OV, Angelova IY, Yunes RA, Zorkina YA, Morozova AY, et al. Alterations of the composition and neurometabolic profile of human gut microbiota in major depressive disorder. Biomedicines. 2022; 10(9): 2162. doi: 10.3390/biomedicines10092162</mixed-citation><mixed-citation xml:lang="en">Kovtun AS, Averina OV, Angelova IY, Yunes RA, Zorkina YA, Morozova AY, et al. Alterations of the composition and neurometabolic profile of human gut microbiota in major depressive disorder. Biomedicines. 2022; 10(9): 2162. doi: 10.3390/biomedicines10092162</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
